Clinical Trial Update: HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating HP 129Xe MRI for assessment of chronic lung allograft dysfunction in lung transplant recipients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Allograft Dysfunction
• Lung Transplant Rejection

Drugs mentioned

• Hyperpolarized Xenon-129 MRI

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Lung Transplant Rejection | Phase 2 | Status: TERMINATED